Autoreactive CD4(+) T cells protect from autoimmune diabetes via bystandersuppression using the IL-4/stat6 pathway

Citation
D. Homann et al., Autoreactive CD4(+) T cells protect from autoimmune diabetes via bystandersuppression using the IL-4/stat6 pathway, IMMUNITY, 11(4), 1999, pp. 463-472
Citations number
50
Categorie Soggetti
Immunology
Journal title
IMMUNITY
ISSN journal
10747613 → ACNP
Volume
11
Issue
4
Year of publication
1999
Pages
463 - 472
Database
ISI
SICI code
1074-7613(199910)11:4<463:ACTCPF>2.0.ZU;2-T
Abstract
Targeted immune regulation can be achieved by use of tissue-specific T cell s and offers the potential for organ-specific suppression of destructive au toimmune processes. Here, we report the generation and characterization of insulin B chain-specific "autoreactive" CD4(+) regulatory T cells that loca lly suppress diabetogenic T cell responses against an unrelated self-antige n (viral transgene) in a virus-induced model for type 1 diabetes. Interleuk in 4 (IL-4) is essential for prevention of diabetes since regulatory T cell s cannot be induced in the absence of IL-4 or stat6 (IL-4 signaling pathway ). Our observations demonstrate that autoreactive regulatory T cells can su ppress autoreactive destructive T cell activity of differential antigenic s pecificity locally in the pancreatic draining lymph node, probably via cyto kine-mediated modulation of antigen-presenting cells.